SEROTONIN 5-HT3 ANTAGONISTS DO NOT ALTER THE DISCRIMINATIVE STIMULUS PROPERTIES OF COCAINE

被引:57
作者
PARIS, JM [1 ]
CUNNINGHAM, KA [1 ]
机构
[1] UNIV TEXAS,MED BRANCH,DEPT PHARMACOL & TOXICOL,GALVESTON,TX 77550
关键词
COCAINE; SEROTONIN; 5-HT3; ICS-205930; MDL-72222; DRUG DISCRIMINATION-BEHAVIOR; RAT;
D O I
10.1007/BF02245652
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The central nervous system (CNS) of the rat is known to contain serotonin (5-HT) type -3 receptors (5-HT3). Behavioral evidence suggests that 5-HT3 receptors interact with mesolimbic dopamine (DA) systems and that 5-HT3 antagonists can interfere with the hyperlocomotive effects of amphetamine and cocaine and the rewarding and stimulus effects of morphine, nicotine and ethanol. Cocaine, which blocks the reuptake of DA, norepinephrine (NE), and 5-HT in the CNS, also may be an antagonist at 5-HT3 receptors. The purpose of the present study was to determine whether systemic administration of the 5-HT3 antagonists ICS 205930 or MDL 72222 could mimic or block the discriminative stimulus properties of cocaine. Once rats (N = 16) were trained to discriminate cocaine (10 mg/kg) from saline, substitution tests with various doses of cocaine (0.313-10 mg/kg), ICS 205930 (2-24 mg/kg), and MDL 72222 (2-16 mg/kg) were conducted. Cocaine produced a dose-related increase in cocaine-appropriate responding while the 5-HT3 antagonists engendered primarily saline-lever responding. Neither ICS 205930 nor MDL 72222 were able to antagonize the stimulus effects of cocaine (5 mg/kg). Response rates were not significantly reduced when the 5-HT3 antagonists were given in combination with cocaine. The results indicate that although 5-HT3 antagonists can inhibit some of the unconditioned behavioral effects of psychomotor stimulants, the discriminative stimulus effects of cocaine remain intact.
引用
收藏
页码:475 / 478
页数:4
相关论文
共 23 条
[1]  
BLANDINA P, 1989, J PHARMACOL EXP THER, V251, P803
[2]   COCAINE INCREASES EXTRACELLULAR DOPAMINE IN RAT NUCLEUS ACCUMBENS AND VENTRAL TEGMENTAL AREA AS SHOWN BY INVIVO MICRODIALYSIS [J].
BRADBERRY, CW ;
ROTH, RH .
NEUROSCIENCE LETTERS, 1989, 103 (01) :97-102
[3]   PHARMACOLOGICAL PROPERTIES OF GR38032F, A NOVEL ANTAGONIST AT 5-HT3 RECEPTORS [J].
BUTLER, A ;
HILL, JM ;
IRELAND, SJ ;
JORDAN, CC ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (02) :397-412
[4]   DOPAMINE-D1 AND DOPAMINE-D2 MEDIATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF D-AMPHETAMINE AND COCAINE [J].
CALLAHAN, PM ;
APPEL, JB ;
CUNNINGHAM, KA .
PSYCHOPHARMACOLOGY, 1991, 103 (01) :50-55
[5]   5-HT3 RECEPTOR ANTAGONISTS BLOCK MORPHINE-INDUCED AND NICOTINE-INDUCED PLACE-PREFERENCE CONDITIONING [J].
CARBONI, E ;
ACQUAS, E ;
LEONE, P ;
PEREZZANI, L ;
DICHIARA, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (01) :159-160
[6]   DIFFERENTIAL INHIBITORY EFFECTS OF A 5-HT3 ANTAGONIST ON DRUG-INDUCED STIMULATION OF DOPAMINE RELEASE [J].
CARBONI, E ;
ACQUAS, E ;
FRAU, R ;
DICHIARA, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 164 (03) :515-519
[7]   EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN [J].
COSTALL, B ;
DOMENEY, AM ;
NAYLOR, RJ ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) :881-894
[8]  
COSTALL B, 1988, British Journal of Pharmacology, V95, p905P
[9]  
COSTALL B, 1987, BRIT J PHARMACOL, V91, pP194
[10]  
CUNNINGHAM KA, 1991, COCAINE PHARM PHYSL